Biodegradable Stents

Biodegradable Stents

Global Biodegradable Stents Market to Reach US$27.2 Billion by 2030

The global market for Biodegradable Stents estimated at US$3.3 Billion in the year 2023, is expected to reach US$27.2 Billion by 2030, growing at a CAGR of 35.0% over the analysis period 2023-2030. Coronary Artery Stents, one of the segments analyzed in the report, is expected to record a 34.8% CAGR and reach US$15.6 Billion by the end of the analysis period. Growth in the Peripheral Artery Stents segment is estimated at 35.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$834.5 Million While China is Forecast to Grow at 42.9% CAGR

The Biodegradable Stents market in the U.S. is estimated at US$834.5 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$8.5 Billion by the year 2030 trailing a CAGR of 42.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 26.9% and 30.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 28.9% CAGR.

Global Biodegradable Stents Market - Key Trends & Drivers Summarized

Why Are Biodegradable Stents Revolutionizing Cardiovascular Care?

Biodegradable stents, also known as bioresorbable stents, are transforming the landscape of cardiovascular treatment by offering a temporary scaffold for arterial support. Unlike traditional metal stents, which remain in the body indefinitely, biodegradable stents dissolve over time, reducing the risk of long-term complications such as in-stent restenosis and thrombosis. As cardiovascular diseases continue to be a leading cause of morbidity and mortality globally, the development of stents that not only restore blood flow but also degrade safely within the body is a major advancement in medical technology. This innovation is crucial for patients requiring minimally invasive treatments with reduced long-term side effects.

What Are the Latest Innovations in Biodegradable Stent Materials?

The development of new materials for biodegradable stents is a major area of focus for medical device manufacturers. Early biodegradable stents were made from materials like polylactic acid (PLA), but research into more advanced polymers and metallic compounds, such as magnesium-based alloys, has opened new possibilities for improved performance. These newer materials offer better mechanical strength, flexibility, and controlled degradation rates, allowing for more tailored solutions to individual patient needs. Moreover, advances in surface coatings are helping to enhance biocompatibility and reduce inflammation, making these stents more effective in the long-term management of cardiovascular health.

How Are Biodegradable Stents Expanding Beyond Cardiology?

While biodegradable stents were initially developed for cardiology applications, their use is expanding into other areas of medicine, such as gastroenterology, urology, and orthopedics. In gastrointestinal procedures, biodegradable stents are used to treat conditions like esophageal strictures, while in urology, they can provide temporary support in the urinary tract. This expansion into new medical fields underscores the versatility of biodegradable stent technology, making it an essential tool in minimally invasive procedures across a broad range of specialties. The ability of these stents to dissolve after serving their purpose is a game-changer for patients who require temporary scaffolding but do not want permanent implants.

What Are the Challenges in Widespread Adoption of Biodegradable Stents?

Despite their advantages, biodegradable stents face several challenges that could limit their widespread adoption. One of the primary concerns is the need for longer-term clinical data to prove their efficacy over traditional stents. While the technology has shown promise in clinical trials, there is still hesitation among some medical professionals due to concerns over mechanical integrity and premature degradation. Furthermore, the high cost of biodegradable stents compared to conventional stents can be a barrier in cost-sensitive healthcare markets. Addressing these concerns through continued research and development is essential to unlock the full potential of this innovative technology. The growth in the biodegradable stents market is driven by several factors, including the increasing prevalence of cardiovascular diseases, advancements in biomaterial technologies, and the growing demand for minimally invasive procedures. As patient preferences shift toward treatments that minimize foreign body retention, biodegradable stents offer a promising solution. Regulatory approvals and clinical trials demonstrating the safety and efficacy of these devices are also propelling market growth. Additionally, the expanding use of biodegradable stents in non-cardiac applications and the rising geriatric population, who are more prone to chronic diseases, are further contributing to the increased demand for these innovative medical devices.

Select Competitors (Total 46 Featured) -

• Abbott Laboratories
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Elixir Medical Corporation
• Kyoto Medical Planning Co., Ltd.
• Sahajanand Medical Technologies Pvt., Ltd.
• Terumo Europe NV

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.